Metraipolis › archive › dc_4dc9a91c4f7c

5-Hydroxymethylcytosine: a key epigenetic mark in cancer and chemotherapy response — Europe PMC PMID:41243111

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41243111
DOI
10.1186/s13072-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-08T12:49:55.170Z
SHA-256 of the archived text
943b56618b684f591fa8fcf491cfa145026e29509d4d3960b4d63b52b9a72f7f
Stable URL of this page
https://metraipolis.com/documento/dc_4dc9a91c4f7c

How to cite

5-Hydroxymethylcytosine: a key epigenetic mark in cancer and chemotherapy response — Europe PMC PMID:41243111 — Europe PMC (en), https://europepmc.org/article/MED/41243111 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4dc9a91c4f7c (Metraipolis archive dc_4dc9a91c4f7c, sha256 943b56618b684f591fa8fcf491cfa145026e29509d4d3960b4d63b52b9a72f7f)
BibTeX
@misc{dc4dc9a91c4f7c,
  title = {5-Hydroxymethylcytosine: a key epigenetic mark in cancer and chemotherapy response — Europe PMC PMID:41243111},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41243111},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4dc9a91c4f7c; sha256 943b56618b684f591fa8fcf491cfa145026e29509d4d3960b4d63b52b9a72f7f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41243111. Agents can read the archived copy with the MCP tool read_document.